MoonLake Immunotherapeutics
MLTX
10.77
-0.18
-1.64%
MoonLake Immunotherapeutics
US · MLTX
#3305 by market cap
Listed 2020
10.77
-0.18
-1.64%
Live - 5344 symbols - heartbeat 271s ago
· 2026-10-08 08:42
Pre-market
10.75
-0.19%
After-hours
10.96
+1.76%
- Market cap
- 916.60M
- P/E (TTM)i
- -2.80
- P/Bi
- 2.14
- EPSi
- -3.53
- Div yieldi
- 0.00%
- 52W posi
- 14%
Reader sentiment
Are you bullish or bearish on MLTX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 1.5 percentage points.
Institutional ownership
- Held by institutions
- 87.43% -1.51pp
- Institutions
- 205 +2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Hedge Fund48.97%
Mutual Fund18.27%
VC/PE Fund13.09%
Individual/Insider7.80%
Private Company3.95%
Public Company2.96%
Government Pension Fund0.11%
Other4.77%
Top holders as of 2026-06-30
BVF Partners L.P.
18.80% · 16.00M sh
Deep Track Capital, LP
8.22% · 7.00M sh
T. Rowe Price Group, Inc.
6.25% · 5.32M sh
D. E. Shaw & Co., L.P.
3.95% · 3.37M sh
Cormorant Asset Management, LP
3.77% · 3.21M sh
Janus Henderson Group plc
3.63% · 3.09M sh
Jorge da Silva
3.26% · 2.77M sh
Kristian Reich
3.23% · 2.75M sh
Logos Global Management, L.P.
3.14% · 2.68M sh
Weiss Asset Management, LLC
3.03% · 2.58M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 23 buys · 27 sells
| Name | Role | Stake |
|---|---|---|
| BVF Partners L.P. | -- | 18.80% |
| Jorge da Silva | Chief Executive Officer | 3.26% |
| Kristian Reich | Co-Founder & CSO | 3.23% |
| Matthias Bodenstedt | Chief Financial Officer | 1.31% |
| Simon Sturge | Independent Chairperson | -- |
| Catherine Moukheibir | Independent Director | -- |
| Cormorant Asset Management, LP | -- | -- |
| Andrew Phillips | Independent Director | -- |
| Ramnik Xavier | Independent Director | -- |
| Spike Loy | Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-26 | Kristian Reich | Co-Founder & CSO | Automatic Disposition | -1,100 | $20.00 |
| 2026-07-21 | Kristian Reich | Co-Founder & CSO | Automatic Disposition | -52,448 | $20.00–20.02 |
| 2026-07-19 | Kristian Reich | Co-Founder & CSO | Automatic Disposition | -43,700 | $20.09 |
| 2026-07-14 | Kristian Reich | Co-Founder & CSO | Automatic Disposition | -16,105 | $20.01 |
| 2026-07-09 | Jorge da Silva | Chief Executive Officer | Automatic Disposition | -102,225 | $20.01–20.02 |
| 2026-06-30 | Jorge da Silva | Chief Executive Officer | Automatic Disposition | -47,775 | $20.03 |
| 2026-06-29 | Jorge da Silva | Chief Executive Officer | Intent to Sell (Form 144) | -150,000 | $20.03 |
| 2026-06-21 | Matthias Bodenstedt | Chief Financial Officer | Automatic Disposition | -39,120 | $22.04 |
| 2026-06-17 | Matthias Bodenstedt | Chief Financial Officer | Automatic Disposition | -17,876 | $19.60–19.68 |
| 2026-06-16 | BVF Partners L.P. | -- | Other Derivative Acquisition | +22,195 | $19.19 |
| 2026-06-16 | Catherine Moukheibir | Independent Director | Other Derivative Acquisition | +22,195 | $19.19 |
| 2026-06-16 | Andrew Phillips | Independent Director | Other Derivative Acquisition | +22,195 | $19.19 |
| 2026-06-16 | Ramnik Xavier | Independent Director | Other Derivative Acquisition | +22,195 | $19.19 |
| 2026-06-16 | Spike Loy | Independent Director | Other Derivative Acquisition | +22,195 | $19.19 |
| 2026-06-16 | Kristian Reich | Co-Founder & CSO | Automatic Disposition | -150,000 | $18.70–19.43 |
| 2026-06-14 | Kristian Reich | Co-Founder & CSO | Intent to Sell (Form 144) | -150,000 | $19.00 |
| 2026-05-10 | Matthias Bodenstedt | Chief Financial Officer | Automatic Disposition | -13,653 | $20.02 |
| 2026-04-13 | Matthias Bodenstedt | Chief Financial Officer | Automatic Disposition | -2,426 | $19.56 |
| 2026-04-12 | Jorge da Silva | Chief Executive Officer | Open Market Disposition | -150,000 | $18.23–18.41 |
| 2026-04-09 | Matthias Bodenstedt | Chief Financial Officer | Automatic Disposition | -87,795 | $18.94–19.51 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:42:36 · For reference only, not investment advice and not tailored to your situation.